Capricor Therapeutics
CAPR
#4967
Rank
โ‚ฌ1.45 B
Marketcap
26,70ย โ‚ฌ
Share price
-8.74%
Change (1 day)
127.26%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -โ‚ฌ72.31 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ11.13 Million. In 2024 the company made an earning of -โ‚ฌ35.43 Million a decrease over its 2023 earnings that were of -โ‚ฌ19.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ72.31 Million104.1%
2024 -โ‚ฌ35.43 Million81.57%
2023 -โ‚ฌ19.52 Million-23.2%
2022 -โ‚ฌ25.41 Million44.93%
2021 -โ‚ฌ17.53 Million46.61%
2020 -โ‚ฌ11.96 Million78.71%
2019 -โ‚ฌ6.69 Million-49.7%
2018 -โ‚ฌ13.3 Million-724.78%
2017 โ‚ฌ2.12 M-112.93%
2016 -โ‚ฌ16.47 Million46.27%
2015 -โ‚ฌ11.26 Million106.82%
2014 -โ‚ฌ5.45 Million-48.41%
2013 -โ‚ฌ10.55 Million977.23%
2012 -โ‚ฌ0.98 Million-77.11%
2011 -โ‚ฌ4.28 Million-22.35%
2010 -โ‚ฌ5.51 Million-20.17%
2009 -โ‚ฌ6.91 Million-41.17%
2008 -โ‚ฌ11.74 Million41.05%
2007 -โ‚ฌ8.32 Million1098.87%
2006 -โ‚ฌ0.7 Million4101.55%
2005 -โ‚ฌ0.02 Million-0.97%
2004 -โ‚ฌ0.02 Million17.87%
2003 -โ‚ฌ0.02 Million3.66%
2002 -โ‚ฌ0.02 Million-30.11%
2001 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.35 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.51 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.66 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.23 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ4.2 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.31 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA